Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exagen (XGN) Preferred Stock Liabilities (2018 - 2019)

Exagen (XGN) has disclosed Preferred Stock Liabilities for 2 consecutive years, with $121.0 million as the latest value for Q2 2019.

  • For the quarter ending Q2 2019, Preferred Stock Liabilities changed N/A year-over-year to $121.0 million, compared with a TTM value of $121.0 million through Jun 2019, changed N/A, and an annual FY2018 reading of $1.5 million, changed N/A over the prior year.
  • Preferred Stock Liabilities was $121.0 million for Q2 2019 at Exagen, up from $1.5 million in the prior quarter.
  • Across five years, Preferred Stock Liabilities topped out at $121.0 million in Q2 2019 and bottomed at $1.5 million in Q4 2018.